Primary Site >> Stomach Cancer

Gene >> TAOK2

  • 1979
  • 1981
  • 1982
  • 1983
  • 1984
  • 1985
  • 1986
  • 1987
  • 1988
  • 1989
  • 1990
  • 1991
  • 1992
  • 1993
  • 1994
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2000
  • 2002
  • 2004
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2015
  • 2016
Ref: Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients.
PMID: 376911
Ref: Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach.
PMID: 6793759
Ref: Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach.
PMID: 6811786
Ref: Postoperative long-term cancer chemotherapy (PLCC) extends life-span of non-curatively resected patients with stage IV gastric cancer.
PMID: 7131965
Ref: [Effect of postoperative long-term cancer chemotherapy (PLCC) on non-curative gastric cancer of stage IV].
PMID: 7184422
Ref: [Effect of PSK on cell-mediated immune status in the patients of stomach cancer].
PMID: 6411001
Ref: Late results of postoperative long-term cancer chemotherapy for the gastric cancer patients subjected to curative resection.
PMID: 6411956
Ref: [Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer].
PMID: 6416183
Ref: [Influence of PSK on the metabolism of FT-207].
PMID: 6433806
Ref: [The restration effect of PSK on the postoperative immunosuppression in patients with gastric cancer].
PMID: 2417925
Ref: [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy].
PMID: 3877822
Ref: [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients].
PMID: 3878935
Ref: [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate].
PMID: 3918509
Ref: [A clinical trial of cis-platinum (II) in combination with PSK and FT-207 in advanced stomach cancer].
PMID: 3920975
Ref: [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
PMID: 3929694
Ref: [Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma].
PMID: 3936946
Ref: [The immune defense system in gastric cancer tissue, regional lymph node and spleen--aspects from subsets and functions of lymphocytes].
PMID: 4088222
Ref: [Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy].
PMID: 3082287
Ref: [A case of adult respiratory distress syndrome (ARDS) induced by radio-chemotherapy (RAFP therapy) of brain metastasis of stomach cancer].
PMID: 3088466
Ref: [Clinical study of PSK as an adjuvant immunochemotherapeutic agent against gastric cancer].
PMID: 3090939
Ref: [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal On
PMID: 3947108
Ref: [A case report of patient with advanced stomach carcinoma of linitis plastica type responding to multi-immunotherapy and chemotherapy].
PMID: 3026254
Ref: [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
PMID: 3103540
Ref: [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai G
PMID: 3307635
Ref: [Immunohistochemical study of spleens in gastric cancer].
PMID: 3501536
Ref: [A long-surviving case of gastric cancer with liver metastasis without signs of recurrence for six years after palliative operation].
PMID: 3560453
Ref: Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years.
PMID: 3150019
Ref: [The minimization method in a medium size clinical trial. Study of immunochemotherapy with PSK in gastric cancer].
PMID: 3289503
Ref: [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
PMID: 2496668
Ref: [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
PMID: 2505682
Ref: The effect and distribution of a protein-bound polysaccharide preparation, PSK (Krestin), intratumorally injected prior to surgery into gastric cancer patients.
PMID: 2610006
Ref: [A long-surviving case of gastric cancer with peritoneal metastasis (P3) responding to short-term high-dose chemotherapy and long-term immunotherapy].
PMID: 2802638
Ref: Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.
PMID: 2111414
Ref: [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
PMID: 2120375
Ref: Augmentation of cytotoxicity of tumor-infiltrating lymphocytes by biological response modifiers.
PMID: 1783460
Ref: Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
PMID: 1786194
Ref: A protein-bound polysaccharide immunomodulator, PSK, does not suppress the conversion from 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in patients with gastric cancer.
PMID: 1802023
Ref: In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer.
PMID: 1901030
Ref: [A long-term survival case of advanced gastric cancer undergoing radical gastrectomy by second-look operation after successful chemotherapy (CDDP, MMC, 5-FU)].
PMID: 1908214
Ref: Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
PMID: 1472793
Ref: [Immunological competence and effect of PSK in patients with gastric cancer and colon cancer: preliminary report].
PMID: 1508143
Ref: Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
PMID: 1558796
Ref: Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
PMID: 1622120
Ref: Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
PMID: 8261578
Ref: [A case of secondary leukemia induced by chemotherapy with a CDDP-based regimen for gastric cancer 5 years following radical resection].
PMID: 8422178
Ref: Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
PMID: 7910230
Ref: Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide.
PMID: 7728773
Ref: Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.
PMID: 7762991
Ref: In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
PMID: 8572620
Ref: [Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
PMID: 8712826
Ref: [A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
PMID: 9170529
Ref: Direct tumor growth suppressive effect of melanoidin extracted from immunomodulator-PSK.
PMID: 10851484
Ref: A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae).
PMID: 9457474
Ref: Protein-tyrosine kinase and protein-serine/threonine kinase expression in human gastric cancer cell lines.
PMID: 9662069
Ref: [Second primary malignancy after surgical adjuvant therapy for gastric cancer].
PMID: 10584564
Ref: The use of mushroom glucans and proteoglycans in cancer treatment.
PMID: 10696116
Ref: [Two patients with liver metastasis from gastric cancer who responded remarkably to combined therapy of 5'-DFUR and PSK].
PMID: 11057326
Ref: Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
PMID: 11448066
Ref: PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.
PMID: 12011998
Ref: Usefulness of immunomodulators for maturation of dendritic cells.
PMID: 15254744
Ref: [Weekly administration of paclitaxel might be beneficial against TS-1-resistant recurrent gastric cancer--a case report].
PMID: 15332551
Ref: [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
PMID: 15553681
Ref: Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
PMID: 17094388
Ref: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer.
PMID: 17106715
Ref: [A case of long-term survival of 5 years after operation and chemotherapy for type 4 gastric cancer with peritoneal dissemination].
PMID: 18195539
Ref: The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.
PMID: 18366723
Ref: [Regression of metastatic hepatic cancer from gastric cancer by polysaccharide K and UFT administration--a case report].
PMID: 19098413
Ref: A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.
PMID: 19414318
Ref: [Ten cases of advanced gastro-intestinal cancer that required preoperative dosage of PSK].
PMID: 20037293
Ref: [A case of metachronous liver metastasis from gastric cancer treated with multidisciplinary therapy including hepatectomy].
PMID: 20037410
Ref: PSK enhances the efficacy of docetaxel in human gastric cancer cells through inhibition of nuclear factor-kappaB activation and survivin expression.
PMID: 20126979
Ref: [Effect of PSK on recurrence of stage II/III gastric cancer].
PMID: 21224540
Ref: [Randomized phase II trial to compare S-1 and S-1/PSK for advanced or recurrent gastric cancer-lessons from the results].
PMID: 22202235
Ref: [S-1/krestin immunochemotherapy for patients with advanced gastric cancer].
PMID: 22202239
Ref: Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.
PMID: 22969994
Ref: [A case of far-advanced gastric cancer successfully treated with S-1/paclitaxel/krestin immunochemotherapy, followed by curative resection].
PMID: 23267881
Ref: The effect of polysaccharide k with S-1 based chemotherapy in advanced gastric cancer.
PMID: 23933930
Ref: Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
PMID: 24100378
Ref: [A case of gastric cancer with peritoneal metastasis successfully treated with multidisciplinary therapy].
PMID: 24394084
Ref: Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
PMID: 24693683
Ref: Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1).
PMID: 25887287
Ref: Improved Efficacy by Addition of Protein-bound Polysaccharide K to Adjuvant Chemotherapy for Advanced Gastric Cancer.
PMID: 27466538
Ref: [Stage IV Gastric Cancer with Positive Peritoneal Washing Cytology or Peritoneal Dissemination Was Successfully Treated with Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy(HIPEC)Followed by Systemic Chemotherapy - A Report of Two Cases].
PMID: 28133187